Skip to content
Screener

EBITDA at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$554.1M+12.4%
Illumina logo
IlluminaILMN
$278M+19.3%
Guardant Health logo
Guardant HealthGH
-$111.91M-11.0%
Natera, Inc. logo
Natera, Inc.NTRA
-$60.31M+40.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$29.79M-97.2%
Myriad Genetics logo
Myriad GeneticsMYGN
-$18.2M-24.7%

Other financials

Income statement

See full
Revenue$109.4M+64.4%
Gross profit$77.1M+77.4%
Operating income$5.5M+438%
Net income$8.1M+3,374%
EPS (diluted)$0.15+850%

Balance sheet

See full
Cash & equivalents$548.6M+190%
Total debt$143.9M
Total equity$536.8M+315%
Total assets$729.7M

Cash flow

See full
Operating cash flow$9.1M+673%
CapEx$4.0M+40.9%
Free cash flow$5.1M+401%

Valuation

See full
Market cap$4.32B-1.8%
Enterprise value$3.92B
P/E114.7×
P/S10.9×

Profitability

See full
Gross margin71.3%+10.3pp
Operating margin10.9%+7.0pp
Net margin9.5%+5.9pp
FCF margin8.3%

Returns & leverage

See full
Return on equity26.3%
Debt / equity0.3×
Current ratio11.7×

Where this comes from

Calculated from BillionToOne, Inc.’s reported figures.

$5.5Mebit+
$1.8MDepreciation Depletion & Amortization
=$7.33M

The source filing: BillionToOne, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:42 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0002070849-26-000050

FAQ

What is BillionToOne, Inc.'s EBITDA?
BillionToOne, Inc. (BLLN) reported EBITDA of $7.33M in Q2 2026.
How has BillionToOne, Inc.'s EBITDA changed year-over-year?
BillionToOne, Inc.'s EBITDA increased by 6010.0% year-over-year, from $120K to $7.33M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about BillionToOne, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude